Nasdaq Stocks: Starbucks & Fastenal to Avoid, Amgen to Watch
Update: 2025-11-25
Description
Starbucks and Fastenal face challenges, with slowing growth and profitability concerns, while Amgen, a biotechnology company, shows promising annual revenue growth and strong free cash flow, making it a potential investment opportunity.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
